tiprankstipranks
Changmao Biochemical Faces Loss Despite Revenue Rise
Company Announcements

Changmao Biochemical Faces Loss Despite Revenue Rise

Changmao Biochemical Engineering Co. Ltd. Class H (HK:0954) has released an update.

Pick the best stocks and maximize your portfolio:

Changmao Biochemical Engineering Co. Ltd. reported a revenue increase to RMB 313,802,000 for the first half of 2024; however, the period ended with a significant loss of RMB 18,786,000 compared to a profit in the previous year. The company also decided against issuing an interim dividend to shareholders, reflecting a focus on financial stability amidst challenging times.

For further insights into HK:0954 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskChangmao Biochemical Set for Key Board Meeting
TipRanks HongKong Auto-Generated NewsdeskChangmao Biochemical Announces H1 2024 Profit Warning
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App